224 related articles for article (PubMed ID: 26134089)
21. Pharmaceutical Pricing in Germany: How Is Value Determined within the Scope of AMNOG?
Lauenroth VD; Stargardt T
Value Health; 2017; 20(7):927-935. PubMed ID: 28712622
[TBL] [Abstract][Full Text] [Related]
22. [Requirements for drug approval and additional benefits assessment: Regulatory aspects and experiences].
Broich K; Löbker W; Schulte A; Beinlich P; Müller T
Nervenarzt; 2016 Apr; 87(4):376-85. PubMed ID: 27003322
[TBL] [Abstract][Full Text] [Related]
23. Implementation of AMNOG: An industry perspective.
Leverkus F; Chuang-Stein C
Biom J; 2016 Jan; 58(1):76-88. PubMed ID: 26332597
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Adjusted and Unadjusted Indirect Comparison Methods in Benefit Assessment. A Simulation Study for Time-to-event Endpoints.
Kühnast S; Schiffner-Rohe J; Rahnenführer J; Leverkus F
Methods Inf Med; 2017 May; 56(3):261-267. PubMed ID: 28361159
[TBL] [Abstract][Full Text] [Related]
25. [Benefit Assessment and Price Negotiation Under AMNOG: Calculable Process or Unfair Poker Game?].
Radic D; Haugk S; Radic M
Gesundheitswesen; 2018 Jun; 80(6):573-579. PubMed ID: 27636366
[TBL] [Abstract][Full Text] [Related]
26. [Impact of early benefit assessment on patients with epilepsy in Germany: Current healthcare provision and therapeutic needs].
Strzelczyk A; Hamer HM
Nervenarzt; 2016 Apr; 87(4):386-93. PubMed ID: 26927680
[TBL] [Abstract][Full Text] [Related]
27. Structural changes in the German pharmaceutical market: price setting mechanisms based on the early benefit evaluation.
Henschke C; Sundmacher L; Busse R
Health Policy; 2013 Mar; 109(3):263-9. PubMed ID: 23339876
[TBL] [Abstract][Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
